Tegio can be stopped in the middle, but need to be stopped according to the treatment cycle, that is, 28 consecutive medication after stopping 14 days as a cycle, not arbitrary stopping. Tegio can inhibit the growth of human gastric and colorectal cancer cells, and is generally used clinically in combination with cisplatin for unresectable locally advanced or metastatic gastric cancer. This product is administered according to the treatment cycle, after 28 consecutive days of administration, rest for 14 days until the patient’s condition deteriorates or is intolerable. The drug should not be discontinued arbitrarily, or the therapeutic effect will be affected. The adverse reactions of this product include leukopenia, thrombocytopenia, anemia, loss of appetite, nausea, vomiting, diarrhea, stomatitis. It is contraindicated for those who are allergic to this product, those with severe bone marrow suppression, severe liver dysfunction, and women during pregnancy. Please use the medicine strictly according to the doctor’s instruction under the guidance of the physician, and do not stop the medicine arbitrarily.